Seneme, E.F.; dos Santos, D.C.; de Lima, C.A.; Zelioli, Í.A.M.; Sciani, J.M.; Longato, G.B.
Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer. Pharmaceuticals 2022, 15, 1233.
https://doi.org/10.3390/ph15101233
AMA Style
Seneme EF, dos Santos DC, de Lima CA, Zelioli ÍAM, Sciani JM, Longato GB.
Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer. Pharmaceuticals. 2022; 15(10):1233.
https://doi.org/10.3390/ph15101233
Chicago/Turabian Style
Seneme, Elisa Frederico, Daiane Carla dos Santos, Carolina Afonso de Lima, Ícaro Augusto Maccari Zelioli, Juliana Mozer Sciani, and Giovanna Barbarini Longato.
2022. "Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer" Pharmaceuticals 15, no. 10: 1233.
https://doi.org/10.3390/ph15101233
APA Style
Seneme, E. F., dos Santos, D. C., de Lima, C. A., Zelioli, Í. A. M., Sciani, J. M., & Longato, G. B.
(2022). Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer. Pharmaceuticals, 15(10), 1233.
https://doi.org/10.3390/ph15101233